Jim Simons acquired 21.7 Thousand Tscan Therapeutics shares worth $159 Thousand. That's 0.00% of their equity portfolio (2974th largest holding). The first Tscan Therapeutics trade was made in Q1 2022. Since then Jim Simons bought shares four more times and sold shares on two occasions. The stake costed the investor $58.9 Thousand, netting the investor a gain of 170% so far.